The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received Marketing ...
Like all medications, baclofen and cyclobenzaprine may cause ... In studies of people taking cyclobenzaprine for back pain, ...
Shares of Marksans Pharma were trading higher in the afternoon session on Tuesday, up 2.14% at ₹207.2 per piece on the BSE at ...
Baclofen is a classic medication for spasticity management ... Some studies have suggested that tizanidine has pain relief properties in addition to its antispasticity effects (Elovic, 2001).
Mumbai: Marksans Pharma Limited's wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for ...
Baclofen 50mcg/mL, 500mcg/mL ... wean orally-administered antispasticity drugs carefully. Do not discontinue abruptly; may result in high fever, altered mental status, rebound spasticity, muscle ...